Celon Pharma S.A. CLN.WA Stock
Celon Pharma S.A. Price Chart
Celon Pharma S.A. CLN.WA Financial and Trading Overview
| Celon Pharma S.A. stock price | 15.58 PLN |
| Previous Close | 16.2 PLN |
| Open | 16.38 PLN |
| Bid | 16.2 PLN x N/A |
| Ask | 16.3 PLN x N/A |
| Day's Range | 16.14 - 16.38 PLN |
| 52 Week Range | 12 - 18.8 PLN |
| Volume | 2.33K PLN |
| Avg. Volume | 42.81K PLN |
| Market Cap | 826.77M PLN |
| Beta (5Y Monthly) | 0.866438 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.67 PLN |
| Forward Dividend & Yield | 0.09 (0.57%) |
| Ex-Dividend Date | June 29, 2023 |
| 1y Target Est | 17.83 PLN |
CLN.WA Valuation Measures
| Enterprise Value | 736.97M PLN |
| Trailing P/E | N/A |
| Forward P/E | -16.530613 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.221193 |
| Price/Book (mrq) | 1.7656677 |
| Enterprise Value/Revenue | 3.763 |
| Enterprise Value/EBITDA | -134.582 |
Trading Information
Celon Pharma S.A. Stock Price History
| Beta (5Y Monthly) | 0.866438 |
| 52-Week Change | 10.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 18.8 PLN |
| 52 Week Low | 12 PLN |
| 50-Day Moving Average | 14.83 PLN |
| 200-Day Moving Average | 14.93 PLN |
CLN.WA Share Statistics
| Avg. Volume (3 month) | 42.81K PLN |
| Avg. Daily Volume (10-Days) | 33.62K PLN |
| Shares Outstanding | 51.04M |
| Float | 21M |
| Short Ratio | N/A |
| % Held by Insiders | 58.83% |
| % Held by Institutions | 13.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.088 |
| Trailing Annual Dividend Yield | 0.54% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -21.056% |
| Operating Margin (ttm) | -20.76% |
| Gross Margin | 64.36% |
| EBITDA Margin | -2.79% |
Management Effectiveness
| Return on Assets (ttm) | -3.92% |
| Return on Equity (ttm) | -8.25% |
Income Statement
| Revenue (ttm) | 195.86M PLN |
| Revenue Per Share (ttm) | 3.84 PLN |
| Quarterly Revenue Growth (yoy) | 4.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5476000 PLN |
| Net Income Avi to Common (ttm) | -41240000 PLN |
| Diluted EPS (ttm) | -0.84 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 134.23M PLN |
| Total Cash Per Share (mrq) | 2.63 PLN |
| Total Debt (mrq) | 27.08M PLN |
| Total Debt/Equity (mrq) | 5.78 PLN |
| Current Ratio (mrq) | 2.046 |
| Book Value Per Share (mrq) | 9.175 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7796000 PLN |
| Levered Free Cash Flow (ttm) | -21987624 PLN |
Profile of Celon Pharma S.A.
| Country | Poland |
| State | N/A |
| City | lomianki |
| Address | ul. Ogrodowa |
| ZIP | 05-092 |
| Phone | 48 227 51 59 33 |
| Website | https://www.celonpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 521 |
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
Q&A For Celon Pharma S.A. Stock
What is a current CLN.WA stock price?
Celon Pharma S.A. CLN.WA stock price today per share is 15.58 PLN.
How to purchase Celon Pharma S.A. stock?
You can buy CLN.WA shares on the Warsaw exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Celon Pharma S.A.?
The stock symbol or ticker of Celon Pharma S.A. is CLN.WA.
Which industry does the Celon Pharma S.A. company belong to?
The Celon Pharma S.A. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Celon Pharma S.A. have in circulation?
The max supply of Celon Pharma S.A. shares is 51.06M.
What is Celon Pharma S.A. Price to Earnings Ratio (PE Ratio)?
Celon Pharma S.A. PE Ratio is now.
What was Celon Pharma S.A. earnings per share over the trailing 12 months (TTM)?
Celon Pharma S.A. EPS is -0.67 PLN over the trailing 12 months.
Which sector does the Celon Pharma S.A. company belong to?
The Celon Pharma S.A. sector is Healthcare.